A new study finds that long-term use of certain drugs commonly prescribed for type 2 diabetes doubles the risk of fracture in women.

According to the study published in the Canadian Medical Association Journal, thiazolidinediones increase the risk of fracture in diabetic women.

The study showed one extra fracture in every 21 senior and postmenopausal diabetic women taking these medications for one year.

Findings revealed no such an association in diabetic men.

Previous studies had reported that thiazolidinediones increase the risk of developing heart failure and heart attack.

Health officials, however, believe the benefits of these medications outweigh their risk and therefore urge individuals to continue the use of these drugs.

Thiazolidinediones are oral medications that help lower blood sugar in type 2 diabetes. Currently available drugs in this group include Actos (pioglitazone), Avandia (rosiglitazone) and a combination drug, Avandamet (rosiglitazone and metformin).

PKH/HGH